The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(2,3-Diphenylquinoxalin-6-yl)-3-(4-(trifluoromethyl)phenyl)urea ID: ALA4861985
PubChem CID: 164621625
Max Phase: Preclinical
Molecular Formula: C28H19F3N4O
Molecular Weight: 484.48
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1ccc(C(F)(F)F)cc1)Nc1ccc2nc(-c3ccccc3)c(-c3ccccc3)nc2c1
Standard InChI: InChI=1S/C28H19F3N4O/c29-28(30,31)20-11-13-21(14-12-20)32-27(36)33-22-15-16-23-24(17-22)35-26(19-9-5-2-6-10-19)25(34-23)18-7-3-1-4-8-18/h1-17H,(H2,32,33,36)
Standard InChI Key: DJFJERVTUXTEEM-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 40 0 0 0 0 0 0 0 0999 V2000
11.4943 -3.0376 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
11.0899 -3.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9069 -3.7429 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.2715 -2.5630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2703 -3.3908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9825 -3.7997 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9807 -2.1541 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6935 -2.5594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6942 -3.3866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4069 -3.7937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1193 -3.3788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1145 -2.5525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4013 -2.1491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8239 -2.1396 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.5382 -2.5439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2475 -2.1310 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.5432 -3.3652 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.9577 -2.5353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9583 -3.3565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6718 -3.7649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3821 -3.3478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3745 -2.5223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6604 -2.1217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5657 -2.1547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5669 -1.3323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8558 -0.9198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1431 -1.3328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1459 -2.1583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8576 -2.5630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5642 -3.7991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8524 -3.3882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1407 -3.7956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1396 -4.6178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8561 -5.0309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5649 -4.6170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0999 -4.5676 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
12 14 1 0
14 15 1 0
15 16 1 0
15 17 2 0
16 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 24 1 0
4 24 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 34 1 0
34 35 2 0
35 30 1 0
5 30 1 0
21 2 1 0
2 36 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 484.48Molecular Weight (Monoisotopic): 484.1511AlogP: 7.63#Rotatable Bonds: 4Polar Surface Area: 66.91Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 11.40CX Basic pKa: 1.12CX LogP: 7.39CX LogD: 7.39Aromatic Rings: 5Heavy Atoms: 36QED Weighted: 0.28Np Likeness Score: -1.19
References 1. Sagar S, Singh S, Mallareddy JR, Sonawane YA, Napoleon JV, Rana S, Contreras JI, Rajesh C, Ezell EL, Kizhake S, Garrison JC, Radhakrishnan P, Natarajan A.. (2021) Structure activity relationship (SAR) study identifies a quinoxaline urea analog that modulates IKKβ phosphorylation for pancreatic cancer therapy., 222 [PMID:34098465 ] [10.1016/j.ejmech.2021.113579 ]